featured
ctDNA Predicts Outcome From First-, but Not Second-Line Treatment in Melanoma Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating Tumor DNA Predicts Outcome From First-, but Not Second-Line Treatment and Identifies Melanoma Patients Who May Benefit From Combination Immunotherapy
Clin. Cancer Res 2020 Oct 16;[EPub Ahead of Print], G Marsavela, J Lee, L Calapre, SQ Wong, MR Pereira, AC McEvoy, AL Reid, C Robinson, L Warburton, A Abed, MA Khattak, TM Meniawy, SJ Dawson, S Sandhu, MS Carlino, AM Menzies, RA Scolyer, GV Long, B Amanuel, M Millward, MR Ziman, H Rizos, ES GrayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.